Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)
NCT01458600
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
65
Enrollment
OTHER
Sponsor class
Conditions
Graves´ Disease
Interventions
DRUG:
Diclofenac
DRUG:
Methimazole
DRUG:
L-thyroxin
DRUG:
Propranolol
DRUG:
Metoprolol
Sponsor
Mikael Lantz